101. Is hemoglobin variation a linear predictor of mortality in acute coronary syndrome?
- Author
-
R. Ferreira, Francisco Rocha Gonçalves, Pedro Monteiro, Sílvia Monteiro, Francisco Soares, Mariano Pego, and Sofia Mendes
- Subjects
medicine.medical_specialty ,Acute coronary syndrome ,lcsh:Diseases of the circulatory (Cardiovascular) system ,Anemia ,030204 cardiovascular system & hematology ,Coronary artery disease ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Clinical endpoint ,Medicine ,030212 general & internal medicine ,Hemoglobin ,business.industry ,Mortality rate ,Retrospective cohort study ,medicine.disease ,Confidence interval ,Risk factors ,lcsh:RC666-701 ,Cardiology ,Coronary care unit ,Coronary artery syndromes ,Cardiology and Cardiovascular Medicine ,business - Abstract
Background and objectives: Coronary artery disease is a common health problem. The aim of this study was to evaluate the prognosis impact on mortality of the variation of hemoglobin (Hb) levels during hospitalization time. Methods: The retrospective observational study included 2640 patients admitted for acute coronary syndrome in a single coronary care unit from May 2004 until June 2013. The primary endpoint was all cause of death at 1 year of follow up time, and secondary endpoint was all cause of death at 2 years of the follow up time. Results: Four groups were created according to the quartiles of Hb variation (admission Hb minus lowest Hb value) during the hospitalization time: group 1: ≥2.1 g/dL with 627 patients; group 2: >1.1 and 0.3 and ≤1.1 g/dL with 686 patients and group 4: ≤0.3 g/dL with 661 patients. A total of 84 patients (3.2%) died during the first year of the follow up. More patients died in group 1 and 4 (6.4% vs 3.7% vs 3.7% vs 6.8%, Log-Rank = 0.023). At 2 years of follow-up, the results were similar, with higher mortality in group 4 (7.3% vs 4.3% vs 4.6% vs 9.2%, Log-Rank = 0.003). Multivariate analysis showed that Hb variation >1.1 was an independent predictor of mortality (hazard ration = 0309 95% confidence interval, 0.136–0.702; P = 0.005). Conclusion: The patients with the lower baseline hemoglobin and the variability of Hb highest than 1.1 mg/dL had the worse prognosis with high mortality rate during the follow up time.
- Published
- 2016
- Full Text
- View/download PDF